商务合作
动脉网APP
可切换为仅中文
CHICAGO & NEW YORK--(BUSINESS WIRE)--Waltz Health, a digital health company developing smarter, technology-enabled ways to price, distribute and prescribe medications and Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced a unique collaboration that will bring employers, and health plans a comprehensive and more affordable weight loss program..
。。
Leveraging Waltz Connect by Waltz Health, the two industry leaders together are engineering a joint solution that will provide an end-to-end program that helps employees more seamlessly access and manage their GLP-1 prescription journey. Waltz Connect is an end-to-end solution that manages all aspects of an organization’s specialty medication coverage.
利用Waltz Health的Waltz Connect,两家行业领导者共同设计了一个联合解决方案,该解决方案将提供端到端的计划,帮助员工更无缝地访问和管理他们的GLP-1处方旅程。Waltz Connect是一种端到端的解决方案,可管理组织专业药物覆盖范围的各个方面。
It includes proprietary technology, patient engagement support, and a first-of-its-kind dynamic marketplace with a network of high-quality specialty pharmacies that compete on price, service levels, and clinical outcomes..
它包括专有技术、患者参与支持,以及第一个具有高质量专业药房网络的动态市场,这些药房在价格、服务水平和临床结果方面都具有竞争力。。
'With GLP-1 medications often priced beyond reach for many, our collaboration with Waltz Health offers a much-needed solution to make these life-changing drugs more accessible and affordable,' said Geoff Cook, Chief Executive Officer of Noom. 'In the U.S., the cost disparity of weight loss drugs compared to other countries has left many employers unable to justify coverage.
Noom首席执行官杰夫·库克(GeoffCook)说:“由于GLP-1药物的价格往往超出了许多人的承受能力,我们与华尔兹健康(Waltz Health)的合作提供了一个急需的解决方案,使这些改变生命的药物更容易获得和负担得起。”在美国,与其他国家相比,减肥药的成本差异使许多雇主无法证明其覆盖范围。
It's simply out of reach. By leveraging Waltz Connect's technology, we're tackling these inflated prices head-on, ensuring that employers can offer their employees a path to effective weight loss that is both transparent and cost-efficient. Together, we are redefining access to care for a condition that affects millions of people with a first-of-its-kind solution, Noom Med with SmartRx.'.
这简直是遥不可及。通过利用Waltz Connect的技术,我们正面应对这些膨胀的价格,确保雇主可以为员工提供一条既透明又具有成本效益的有效减肥途径。我们共同努力,通过首个同类解决方案,Noom Med with SmartRx,重新定义了对数百万人产生影响的疾病的护理服务。”。
The joint employer solution will be part of Noom Med, a clinical obesity management solution that combines evidence-based obesity care with an award-winning behavior change program to help members achieve sustained weight loss while lowering employer costs. Once an employee qualifies for a GLP-1 prescription, Waltz Connect will seamlessly support the patient with access to their prescribed medication, including dispensing and application of all available discounts for a market-leading lower price.
联合雇主解决方案将是Noom Med的一部分,Noom Med是一种临床肥胖管理解决方案,将循证肥胖护理与屡获殊荣的行为改变计划相结合,以帮助成员实现持续减肥,同时降低雇主成本。一旦员工有资格获得GLP-1处方,Waltz Connect将无缝支持患者获得处方药,包括配药和应用所有可用折扣,以市场领先的较低价格。
Employees can see their price in advance in the Noom app before proceeding. This will result in unprecedented price transparency for employees, which will result in a better medication fulfillment experience while also saving their employer more money..
。这将为员工带来前所未有的价格透明度,这将带来更好的用药体验,同时也为雇主节省更多资金。。
“GLP-1 drugs have been a game-changer in the health and wellness space, but supply chain challenges and affordability issues have created broken experiences for many while wholly eliminating access for others. However, we know that there are opportunities to eliminate friction and find savings within the system by intelligently routing prescriptions using AI to uncover the best pharmacy option,” said Waltz Health Co-founder and CEO Mark Thierer.
Waltz health联合创始人兼首席执行官马克·蒂勒(Mark Thierer)表示:“GLP-1药物一直是健康和健康领域的游戏规则改变者,但供应链挑战和负担能力问题给许多人带来了不好的体验,同时也完全消除了其他人的使用机会。然而,我们知道,通过使用人工智能智能智能路由处方,可以消除摩擦,并在系统内找到节省,从而发现最佳的药房选择。”。
“People shouldn’t have to spend their time searching for pharmacies that have medications in stock or who have the best price. By combining Noom’s personalized, behavior science-driven program with our Waltz Connect platform, we’re ensuring employees both have access to more affordable medications and understand when and how to expect their prescriptions.”.
“人们不应该花时间寻找有库存药物或价格最好的药店。通过将Noom的个性化行为科学驱动计划与我们的Waltz Connect平台相结合,我们可以确保员工都能获得更实惠的药物,并了解何时以及如何期望他们的处方。”。
Launched in August, Waltz Connect provides unmatched transparency by unlocking competition among specialty pharmacies and is engineered to reduce specialty costs, improve member experience and deliver better member health outcomes. Its flexible design allows it to be deployed across entire specialty-drug formularies, on specific drug classes like GLP-1s, or even down to individual drugs.
Waltz Connect于8月推出,通过解锁专业药店之间的竞争,提供无与伦比的透明度,旨在降低专业成本,改善会员体验并提供更好的会员健康结果。其灵活的设计允许它部署在整个专业药物处方集中,特定药物类别(如GLP-1)上,甚至可以部署到单个药物。
The solution is built on Waltz Health’s Intelligent Specialty Engine, which is an AI-enabled prescription routing software that intuitively finds the best and most appropriate specialty pharmacy option based on specific criteria selected by each payer..
该解决方案基于Waltz Health的智能专业引擎,该引擎是一种支持人工智能的处方路由软件,可以根据每个付款人选择的特定标准直观地找到最佳和最合适的专业药房选项。。
Workers who are overweight and those experiencing obesity are estimated to have caused a staggering $425.5 billion to U.S. businesses and employees. While GLP-1 drugs have been shown to be a very effective treatment for obesity and associated cardiovascular issues, they can be cost-prohibitive for many people and their employees..
据估计,超重和肥胖的工人给美国企业和员工造成了惊人的4255亿美元。虽然GLP-1药物已被证明是肥胖和相关心血管问题的非常有效的治疗方法,但对许多人及其员工来说,它们的成本可能过高。。
About Waltz Health
关于华尔兹健康
Waltz Health is a digital health company developing technologies and services that support better-informed decisions on prescription care. Designed for payers, pharmacies, pharmacy benefit managers and self-insured employers, the company offers AI-driven marketplaces to lower overall drug costs, providing better pricing options and more information for consumers while also helping payers take control of their pharmacy benefits.
华尔兹健康是一家数字健康公司,开发技术和服务,以支持在处方护理方面做出更明智的决定。该公司为付款人、药店、药房福利管理人员和自保雇主设计,提供人工智能驱动的市场,以降低总体药物成本,为消费者提供更好的定价选择和更多信息,同时帮助付款人控制其药房福利。
Founded in 2021 by Mark Thierer and Jonathon Thierer, Waltz Health is headquartered in Chicago and is backed by GV, Define Ventures, Echo Health Ventures, Blue Venture Fund, Byers Capital, and Twine Ventures. For more information, visit www.waltzhealth.com..
Waltz Health由Mark Thierer和Jonathon Thierer于2021年成立,总部位于芝加哥,由GV、Define Ventures、Echo Health Ventures、Blue Venture Fund、Byers Capital和Twine Ventures支持。有关更多信息,请访问www.waltzhealth.com。。
About Noom
关于Noom
Noom is a digital healthcare company empowering everyone, everywhere to live better longer, through an unwavering commitment to innovation and whole-person health. Noom connects people to content, coaching, community, and clinicians to promote positive behavior and healthy habits, in an effort to promote healthspan and better living.
Noom是一家数字医疗保健公司,通过坚定不移地致力于创新和全人健康,让世界各地的每个人都能活得更好。Noom将人们与内容、教练、社区和临床医生联系起来,以促进积极的行为和健康的习惯,从而促进健康和更好的生活。
Noom also works with leading health plans and employers offering Noom Med Center Of Excellence, Noom GLP-1 Companion, Noom Healthy Weight, and Noom Diabetes Prevention to millions of covered lives. The company has been awarded multiple grants from the National Institutes of Health and was the first mobile application to be recognized by the Centers for Disease Control and Prevention as a certified diabetes prevention program.
Noom还与领先的健康计划和雇主合作,为数百万受保生命提供Noom Med卓越中心、Noom GLP-1伴侣、Noom健康体重和Noom糖尿病预防。该公司获得了美国国立卫生研究院(National Institutes of Health)的多项资助,是美国疾病控制与预防中心(Centers for Disease Control and Prevention)认可的首个经认证的糖尿病预防计划移动应用程序。
With offices in New York City and Princeton, NJ, Noom has been named one of Inc.'s Best Places to Work, Quartz's Best Workplaces for Remote Workers, and Fortune's Best Workplaces in Technology. For more information, please visit noom.com, subscribe to our blog, or follow us on Twitter and LinkedIn..
努姆在纽约市和新泽西州普林斯顿设有办事处,被评为Inc.最佳工作场所之一、Quartz最佳远程工作者工作场所和Fortune最佳技术工作场所。有关更多信息,请访问noom.com,订阅我们的博客,或在Twitter和LinkedIn上关注我们。。